AAV1-gamma-sarcoglycan vector injection

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
113	筋ジストロフィー	1

113. 筋ジストロフィー

臨床試験数 : 646 / 薬物数 : 471 - (DrugBank : 105) / 標的遺伝子数 : 59 - 標的パスウェイ数 : 170

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01344798 (ClinicalTrials.gov)	November 2006	17/3/2011	Clinical Study of AAV1-gamma-sarcoglycan Gene Therapy for Limb Girdle Muscular Dystrophy Type 2C	Phase I Clinical Study of AAV1-gamma-sarcoglycanGene Therapy for Limb Girdle Muscular Dystrophy Type ...	Limb Girdle Muscular Dystrophy Type 2C;Gamma-sarcoglycanopathy	Biological: AAV1-gamma-sarcoglycan vector injection	Genethon	NULL	Completed	15 Years	N/A	Both	9	Phase 1	France

First Previous1Next Last